Singapore markets closed

TG Therapeutics, Inc. (TGTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
15.21-0.36 (-2.31%)
At close: 04:00PM EDT
15.37 +0.16 (+1.05%)
After hours: 07:52PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
233,662
233,662
2,785
6,689
152
Cost of revenue
14,131
14,131
265
790
0
Gross profit
219,531
219,531
2,520
5,899
152
Operating expenses
Research development
63,182
63,182
112,128
198,532
151,934
Selling general and administrative
135,716
135,716
83,231
152,137
121,812
Total operating expenses
198,898
198,898
195,359
350,669
273,746
Operating income or loss
20,633
20,633
-192,839
-344,770
-273,594
Interest expense
12,615
12,615
10,191
5,638
6,329
Total other income/expenses net
5,044
5,044
4,695
2,307
542
Income before tax
13,062
13,062
-198,335
-348,101
-279,381
Income tax expense
390
390
0
0
-
Income from continuing operations
12,672
12,672
-198,335
-348,101
-279,381
Net income
12,672
12,672
-198,335
-348,101
-279,381
Net income available to common shareholders
12,672
12,672
-198,335
-348,101
-279,381
Basic EPS
-1.46
0.09
-1.46
-2.63
-2.42
Diluted EPS
-1.46
0.09
-1.46
-2.63
-2.42
Basic average shares
135,411
141,955
135,411
132,223
115,334
Diluted average shares
135,411
148,508
135,411
132,223
115,334